AlzChem Group AG
XETRA:ACT
Intrinsic Value
AlzChem Group AG engages in the development, production, and marketing of chemical products. [ Read More ]
The intrinsic value of one ACT stock under the Base Case scenario is 50.43 EUR. Compared to the current market price of 46.7 EUR, AlzChem Group AG is Undervalued by 7%.
Valuation Backtest
AlzChem Group AG
Run backtest to discover the historical profit from buying and selling ACT stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
AlzChem Group AG
Current Assets | 216.6m |
Cash & Short-Term Investments | 11.9m |
Receivables | 97.2m |
Other Current Assets | 107.5m |
Non-Current Assets | 208.1m |
Long-Term Investments | 6k |
PP&E | 182.1m |
Intangibles | 3.7m |
Other Non-Current Assets | 22.3m |
Current Liabilities | 82.6m |
Accounts Payable | 31.6m |
Other Current Liabilities | 51.1m |
Non-Current Liabilities | 180.4m |
Long-Term Debt | 52m |
Other Non-Current Liabilities | 128.4m |
Earnings Waterfall
AlzChem Group AG
Revenue
|
540.6m
EUR
|
Cost of Revenue
|
-232.6m
EUR
|
Gross Profit
|
308.1m
EUR
|
Operating Expenses
|
-251m
EUR
|
Operating Income
|
57.1m
EUR
|
Other Expenses
|
-22.5m
EUR
|
Net Income
|
34.6m
EUR
|
Free Cash Flow Analysis
AlzChem Group AG
What is Free Cash Flow?
ACT Profitability Score
Profitability Due Diligence
AlzChem Group AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
AlzChem Group AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
ACT Solvency Score
Solvency Due Diligence
AlzChem Group AG's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Score
AlzChem Group AG's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ACT Price Targets Summary
AlzChem Group AG
According to Wall Street analysts, the average 1-year price target for ACT is 37.1 EUR with a low forecast of 29.29 EUR and a high forecast of 42 EUR.
Shareholder Return
ACT Price
AlzChem Group AG
Average Annual Return | -1.08% |
Standard Deviation of Annual Returns | 13.45% |
Max Drawdown | -43% |
Market Capitalization | 475.2m EUR |
Shares Outstanding | 10 176 300 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
AlzChem Group AG engages in the development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,636 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
Contact
IPO
Employees
Officers
The intrinsic value of one ACT stock under the Base Case scenario is 50.43 EUR.
Compared to the current market price of 46.7 EUR, AlzChem Group AG is Undervalued by 7%.